Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lanthier

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Internal Medicine Journal|December 14, 2011
Low-dose ionising radiation from medical imaging in patients hospitalised in Internal MedicineD Martineau-Beaulieu, L Lanthier
Gut|April 1, 1985
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactuloseP L Lanthier, M Y Morgan
La Revue De Medecine Interne|January 18, 2021
[In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|September 13, 2023
[Does pitavastatine prevent atherosclerotic cardiovascular events in people living with HIV on antiretroviral therapy with low to moderate cardiovascular risk, and is it safe?]L Lanthier, M-E Plourde, M Cauchon
La Revue De Medecine Interne|March 13, 2022
[In symptomatic, nonhospitalized unvaccinated adults with mild to moderate COVID-19 at risk for progression to severe disease, does nirmatrelvir/ritonavir decrease the risk of COVID-19-related hospitalization or all-cause mortality while being safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|February 22, 2024
[Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|September 19, 2022
[In patients hospitalized for COVID-19, does baricitinib reduce 28-days mortality compared to standard treatment, and is it safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|June 7, 2024
[Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|June 21, 2022
[In high-risk patients undergoing noncardiac surgery, does tranexamic acid result in a lower incidence of bleeding while being safe from a cardiovascular point of view compared to placebo?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|January 7, 2023
[In patients hospitalized for acute heart failure, is a strategy combining rapid and close follow-up visits with laboratories (including NT-proBNP) and rapid up-titration of treatments effective and safe?]L Lanthier, M-É Plourde, M Cauchon
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Internal Medicine Journal|December 14, 2011
Low-dose ionising radiation from medical imaging in patients hospitalised in Internal MedicineD Martineau-Beaulieu, L Lanthier
Gut|April 1, 1985
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactuloseP L Lanthier, M Y Morgan
La Revue De Medecine Interne|January 18, 2021
[In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|September 13, 2023
[Does pitavastatine prevent atherosclerotic cardiovascular events in people living with HIV on antiretroviral therapy with low to moderate cardiovascular risk, and is it safe?]L Lanthier, M-E Plourde, M Cauchon
La Revue De Medecine Interne|March 13, 2022
[In symptomatic, nonhospitalized unvaccinated adults with mild to moderate COVID-19 at risk for progression to severe disease, does nirmatrelvir/ritonavir decrease the risk of COVID-19-related hospitalization or all-cause mortality while being safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|February 22, 2024
[Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|September 19, 2022
[In patients hospitalized for COVID-19, does baricitinib reduce 28-days mortality compared to standard treatment, and is it safe?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|June 7, 2024
[Among patients with acute myocardial infarction who had undergone coronary angiography and with preserved left ventricular ejection fraction, does long-term beta-blocker therapy lower the risk of death or recurrent myocardial infarction?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|June 21, 2022
[In high-risk patients undergoing noncardiac surgery, does tranexamic acid result in a lower incidence of bleeding while being safe from a cardiovascular point of view compared to placebo?]L Lanthier, M-É Plourde, M Cauchon
La Revue De Medecine Interne|January 7, 2023
[In patients hospitalized for acute heart failure, is a strategy combining rapid and close follow-up visits with laboratories (including NT-proBNP) and rapid up-titration of treatments effective and safe?]L Lanthier, M-É Plourde, M Cauchon
Pageof 5